Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)

January 17, 2020
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Series: 2019 novel coronavirus, Wuhan, China

[PDF-56.95 KB]

English

Details Supporting Files Related Documents You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Health care providers should contact their local/state health department immediately to notify them of patients with fever and lower respiratory illness who traveled to Wuhan, China within 14 days of symptom onset. Local and state public health staff will determine if the patient meets the criteria for a patient under investigation (PUI) for 2019 Novel Coronavirus (2019-nCoV). Clinical specimens should be collected from PUIs for routine testing of respiratory pathogens at either clinical or public health labs. Note that clinical laboratories should NOT attempt viral isolation from specimens collected from 2019-nCoV PUIs.

At this time, diagnostic testing for 2019-nCoV can be conducted only at CDC.

State and local health departments who have identified a PUI should immediately notify CDC’s Emergency Operations Center (EOC) at 770-488-7100 to report the PUI and determine whether testing for 2019-NCoV at CDC is indicated. The EOC will assist local/state health departments to collect, store, and ship specimens appropriately to CDC, including during afterhours or on weekends/holidays.

Testing for other respiratory pathogens by the provider should be done as part of the initial evaluation and should not delay specimen shipping to CDC.

If a PUI tests positive for another respiratory pathogen, after clinical evaluation and consultation with public health authorities, they may no longer be considered a PUI.
Subjects:

[+]

Clinical Laboratory Techniques Communicable Diseases, Emerging Containment Of Biohazards Coronavirus Infections COVID-19 COVID-19 Testing Respiratory Tract Infections/diagnosis Safety Specimen Handling
Series:

2019 novel coronavirus, Wuhan, China
Document Type:

Webpage
Genre:

Guideline
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

[+]

urn:sha256:a2c41c892cfb75f79cad12bd8940d556bd1859b5cac6027c151d97cefa23db28
Download URL:

https://stacks.cdc.gov/view/cdc/84426/cdc_84426_DS1.pdf
File Type:

guidelines-clinical-specimens.html

htm

More +